Stover EH, Baco MB, Cohen O, et al. Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer. Mol Cancer Res. 2019;17(11):2281-2293. doi:10.1158/1541-7786.MCR-18-1243
Smith I, Greenside PG, Natoli T, et al. Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map. PLoS Biol. 2017;15(11):e2003213. doi:10.1371/journal.pbio.2003213
Schilit SLP, Morton CC. 3C-PCR: a novel proximity ligation-based approach to phase chromosomal rearrangement breakpoints with distal allelic variants. Hum Genet. 2018;137(1):55-62. doi:10.1007/s00439-017-1853-0
Auslander N, Cunningham CE, Toosi BM, et al. An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer. Mol Syst Biol. 2017;13(12):956. doi:10.15252/msb.20177739
Lee PH, Lee C, Li X, Wee B, Dwivedi T, Daly M. Principles and methods of in-silico prioritization of non-coding regulatory variants. Hum Genet. 2018;137(1):15-30. doi:10.1007/s00439-017-1861-0
Radovich M, Pickering CR, Felau I, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 2018;33(2):244-258.e10. doi:10.1016/j.ccell.2018.01.003
Passer AR, Coelho MA, Billmyre RB, et al. Genetic and Genomic Analyses Reveal Boundaries between Species Closely Related to Pathogens. mBio. 2019;10(3). doi:10.1128/mBio.00764-19
Clark AR, Greka A. The power of one: advances in single-cell genomics in the kidney. Nat Rev Nephrol. 2020;16(2):73-74. doi:10.1038/s41581-019-0237-1
Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer. 2020;20(1):42-56. doi:10.1038/s41568-019-0223-8
Olalde I, Brace S, Allentoft ME, et al. The Beaker phenomenon and the genomic transformation of northwest Europe. Nature. 2018;555(7695):190-196. doi:10.1038/nature25738